PSU Watch logo

| Discoms' outstanding dues to power Gencos rise nearly 24% to Rs 1.36 lakh crore in Dec 2020 |   | Bharatiya Mazdoor Sangh plans protest against disinvestment of PSUs from March 15 to Nov 11 |   | Deadline for filing GST returns extended till March 31 |  

Sunil Kumar Kaimal set to be new MD of Karnataka Antibiotics & Pharmaceuticals Ltd

Kaimal’s name has been recommended by the Public Enterprise Selection Board (PESB) from a list of six candidates

Sunil Kumar Kaimal set to be new MD of Karnataka Antibiotics & Pharmaceuticals Ltd
Sunil Kumar Kaimal set to be new MD of Karnataka Antibiotics & Pharmaceuticals Ltd

New Delhi: Sunil Kumar Kaimal, who is currently serving as General Manager at Karnataka Antibiotics & Pharmaceuticals Limited (KAPL), is going to take over as the Managing Director of the pharma public sector undertaking (PSU). Kaimal’s name has been recommended by the Public Enterprise Selection Board (PESB) from a list of six candidates. Barring him, there were two other people from within the pharma PSU.

ALSO READ: Sunil Kumar Kaimal set to be new MD of Karnataka Antibiotics & Pharmaceuticals Ltd

The other candidates were from Hindustan Organic Chemicals Limited (HOCL) and Bharat Sanchar Nigam Limited (BSNL). Another candidate was a Commodore-level officer from the Indian Navy.

(PSU Watch- India's Business News centre that places the spotlight on PSUs, Bureaucracy, Defence and Public Policy is now on Telegram. Join PSU Watch Channel in your Telegram and stay updated)